SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001385508-19-000029
Filing Date
2019-03-21
Accepted
2019-03-21 16:10:56
Documents
4
Period of Report
2019-03-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8k_earningsrelease.htm 8-K 26938
2 EXHIBIT 99.1 opnt_4qfy18financialresult.htm EX-99.1 30871
3 opnt4qfy18_image2a03.gif GRAPHIC 146178
4 opnt4qfy18f_image1a03.gif GRAPHIC 174323
  Complete submission text file 0001385508-19-000029.txt   500921
Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38193 | Film No.: 19697143
SIC: 1000 Metal Mining